Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783182671> ?p ?o ?g. }
- W2783182671 abstract "Combined antiretroviral therapy (cART) in HIV-infected patients has been associated with lipodystrophy, metabolic abnormalities, and an increased risk of cardiovascular disease. Ultrasound measures of carotid artery intima-media thickness (cIMT) have been used as a valid measure of subclinical atherosclerosis and as a tool to predict the risk of cardiovascular events. Our aim was to evaluate the progression of cIMT in HIV-infected patients subjected to cART, with and without lipodystrophy, over a one-year period. We performed a one-year prospective cohort study to compare changes in cIMT, metabolic and inflammation markers in HIV-infected patients undergoing cART. Body composition was assessed by dual-energy X-ray absorptiometry (DXA) and abdominal computed tomography (CT). Levels of blood pressure, lipids and inflammatory markers were evaluated, as well as ultrasound measures of cIMT. Lipodystrophy defined by Fat Mass Ratio (L-FMR) is measured as the ratio of the percentage of trunk fat mass to the percentage of lower limb fat mass by DXA. Categorical variables were compared, using the chi-square or Fisher’s exact test. Wilcoxon ranks tests and the McNemar chi-square tests were used to compare results of selected variables, from the first to the second year of evaluation. Means of cIMT, adjusted for age, glucose, triglycerides levels, systolic blood pressure (SBP), and waist to hip ratio were calculated, using generalised linear models for repeated measures. L-FMR was present in 44.3% of patients, and the mean of cIMT increased significantly in this group [0.82 (0.26) vs 0.92 (0.33); p = 0.037], as well as in patients without lipodystrophy [0.73 (0.20) vs 0.84 (0.30); p = 0.012]. In the overall sample, the progression of cIMT was statistically significant after the adjustment for age, glucose, triglycerides, and SBP, but the significance of the progression ceased after the adjustment for waist/hip ratio [0.770 (0.737–0.803) vs 0.874 (0.815–0.933); p = 0.514]. Carotid IMT progressed significantly in both groups of this HIV-infected cohort, however no association between the progression of cIMT and the presence of lipodystrophy defined by FMR was found. Visceral adipose tissue had an impact on the increment of cIMT, both in patients with, and without lipodystrophy defined by FMR." @default.
- W2783182671 created "2018-01-26" @default.
- W2783182671 creator A5025107493 @default.
- W2783182671 creator A5025832509 @default.
- W2783182671 creator A5031491158 @default.
- W2783182671 creator A5035998429 @default.
- W2783182671 creator A5040017231 @default.
- W2783182671 creator A5069225490 @default.
- W2783182671 creator A5086432633 @default.
- W2783182671 creator A5091431743 @default.
- W2783182671 date "2018-01-11" @default.
- W2783182671 modified "2023-10-08" @default.
- W2783182671 title "Visceral adipose tissue and carotid intima-media thickness in HIV-infected patients undergoing cART: a prospective cohort study" @default.
- W2783182671 cites W1487927742 @default.
- W2783182671 cites W154254363 @default.
- W2783182671 cites W1573558157 @default.
- W2783182671 cites W172885936 @default.
- W2783182671 cites W1973594065 @default.
- W2783182671 cites W1991828742 @default.
- W2783182671 cites W1995497236 @default.
- W2783182671 cites W2014870367 @default.
- W2783182671 cites W2027386164 @default.
- W2783182671 cites W2028657303 @default.
- W2783182671 cites W2058021232 @default.
- W2783182671 cites W2058331351 @default.
- W2783182671 cites W2063170999 @default.
- W2783182671 cites W2068400385 @default.
- W2783182671 cites W2072744115 @default.
- W2783182671 cites W2076809766 @default.
- W2783182671 cites W2084136758 @default.
- W2783182671 cites W2093449437 @default.
- W2783182671 cites W2101738718 @default.
- W2783182671 cites W2108634795 @default.
- W2783182671 cites W2110713453 @default.
- W2783182671 cites W2120491756 @default.
- W2783182671 cites W2121405280 @default.
- W2783182671 cites W2127518515 @default.
- W2783182671 cites W2132753365 @default.
- W2783182671 cites W2134099620 @default.
- W2783182671 cites W2139638937 @default.
- W2783182671 cites W2148007597 @default.
- W2783182671 cites W2157138119 @default.
- W2783182671 cites W2159285468 @default.
- W2783182671 cites W2160234571 @default.
- W2783182671 cites W2160921359 @default.
- W2783182671 cites W2293262018 @default.
- W2783182671 cites W2316167515 @default.
- W2783182671 cites W2318289184 @default.
- W2783182671 cites W2318775435 @default.
- W2783182671 cites W2322335656 @default.
- W2783182671 cites W2607031541 @default.
- W2783182671 cites W4230870013 @default.
- W2783182671 cites W75304703 @default.
- W2783182671 doi "https://doi.org/10.1186/s12879-017-2884-9" @default.
- W2783182671 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5765644" @default.
- W2783182671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29325542" @default.
- W2783182671 hasPublicationYear "2018" @default.
- W2783182671 type Work @default.
- W2783182671 sameAs 2783182671 @default.
- W2783182671 citedByCount "12" @default.
- W2783182671 countsByYear W27831826712018 @default.
- W2783182671 countsByYear W27831826712019 @default.
- W2783182671 countsByYear W27831826712020 @default.
- W2783182671 countsByYear W27831826712021 @default.
- W2783182671 countsByYear W27831826712022 @default.
- W2783182671 countsByYear W27831826712023 @default.
- W2783182671 crossrefType "journal-article" @default.
- W2783182671 hasAuthorship W2783182671A5025107493 @default.
- W2783182671 hasAuthorship W2783182671A5025832509 @default.
- W2783182671 hasAuthorship W2783182671A5031491158 @default.
- W2783182671 hasAuthorship W2783182671A5035998429 @default.
- W2783182671 hasAuthorship W2783182671A5040017231 @default.
- W2783182671 hasAuthorship W2783182671A5069225490 @default.
- W2783182671 hasAuthorship W2783182671A5086432633 @default.
- W2783182671 hasAuthorship W2783182671A5091431743 @default.
- W2783182671 hasBestOaLocation W27831826711 @default.
- W2783182671 hasConcept C126322002 @default.
- W2783182671 hasConcept C127413603 @default.
- W2783182671 hasConcept C142462285 @default.
- W2783182671 hasConcept C164705383 @default.
- W2783182671 hasConcept C188816634 @default.
- W2783182671 hasConcept C203014093 @default.
- W2783182671 hasConcept C2776193436 @default.
- W2783182671 hasConcept C2777275308 @default.
- W2783182671 hasConcept C2779339615 @default.
- W2783182671 hasConcept C2780221984 @default.
- W2783182671 hasConcept C2780941825 @default.
- W2783182671 hasConcept C2987047532 @default.
- W2783182671 hasConcept C2993143319 @default.
- W2783182671 hasConcept C3013748606 @default.
- W2783182671 hasConcept C71924100 @default.
- W2783182671 hasConcept C72563966 @default.
- W2783182671 hasConcept C78519656 @default.
- W2783182671 hasConcept C84393581 @default.
- W2783182671 hasConceptScore W2783182671C126322002 @default.
- W2783182671 hasConceptScore W2783182671C127413603 @default.
- W2783182671 hasConceptScore W2783182671C142462285 @default.
- W2783182671 hasConceptScore W2783182671C164705383 @default.
- W2783182671 hasConceptScore W2783182671C188816634 @default.
- W2783182671 hasConceptScore W2783182671C203014093 @default.